Michael Alfieri - Net Worth and Insider Trading
Michael Alfieri Net Worth
The estimated net worth of Michael Alfieri is at least $0 dollars as of 2024-12-26. Michael Alfieri is the Principle Financial Officer of Genocea Biosciences Inc and owns about 1,250 shares of Genocea Biosciences Inc (GNCAQ) stock worth over $0. Details can be seen in Michael Alfieri's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that Michael Alfieri has not made any transactions after 2018-09-13 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of Michael Alfieri
Michael Alfieri Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Michael Alfieri owns 5 companies in total, including Proteostasis Therapeutics Inc (PTI) , Genocea Biosciences Inc (GNCAQ) , and Yumanity Therapeutics Inc (YMTX) among others .
Click here to see the complete history of Michael Alfieri’s form 4 insider trades.
Insider Ownership Summary of Michael Alfieri
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PTI | Proteostasis Therapeutics Inc | 2020-05-12 | Interim Head of Finance |
| GNCAQ | Genocea Biosciences Inc | 2018-09-13 | Principle Financial Officer |
| YMTX | Yumanity Therapeutics Inc | 2020-05-12 | Interim Head of Finance |
 | | 2020-05-12 | Interim Head of Finance |
| | 2018-06-21 | Principle Financial Officer |
Michael Alfieri Latest Holdings Summary
Michael Alfieri currently owns a total of 1 stock. Michael Alfieri owns 1,250 shares of Genocea Biosciences Inc (GNCAQ) as of September 13, 2018, with a value of $0.
Latest Holdings of Michael Alfieri
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| GNCAQ | Genocea Biosciences Inc | 2018-09-13 | 1,250 | 0.00 | 0 |
Holding Weightings of Michael Alfieri
Michael Alfieri Form 4 Trading Tracker
According to the SEC Form 4 filings, Michael Alfieri has made a total of 0 transactions in Genocea Biosciences Inc (GNCAQ) over the past 5 years. The most-recent trade in Genocea Biosciences Inc is the acquisition of 1,250 shares on September 13, 2018, which cost Michael Alfieri around $5,400.
Insider Trading History of Michael Alfieri
- 1
Michael Alfieri Trading Performance
GuruFocus tracks the stock performance after each of Michael Alfieri's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Michael Alfieri is 5.85%. GuruFocus also compares Michael Alfieri's trading performance to market benchmark return within the same time period. The performance of stocks bought by Michael Alfieri within 3 months outperforms 1 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Michael Alfieri's insider trading performs compared to the benchmark.
Performance of Michael Alfieri
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 43.56 | | | | | |
| Relative Return to S&P 500(%) | 48.28 | | | | | |
Michael Alfieri Ownership Network
Michael Alfieri Owned Company Details
What does Proteostasis Therapeutics Inc do?
Who are the key executives at Proteostasis Therapeutics Inc?
Michael Alfieri is the Interim Head of Finance of Proteostasis Therapeutics Inc. Other key executives at Proteostasis Therapeutics Inc include director & President and CEO Meenu Chhabra , Chief Scientific Officer Benito Munoz , and See Remarks Eric D Larson .
Proteostasis Therapeutics Inc (PTI) Insider Trades Summary
In summary, during the past 3 months, insiders sold 0 shares of Proteostasis Therapeutics Inc (PTI) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Proteostasis Therapeutics Inc (PTI) were sold and 0 shares were bought by its insiders, resulting in a net sale of 0 shares.
Proteostasis Therapeutics Inc (PTI)'s detailed insider trading history can be found in Insider Trading Tracker table.
Proteostasis Therapeutics Inc Insider Transactions
Michael Alfieri Mailing Address
Above is the net worth, insider trading, and ownership report for Michael Alfieri. You might contact Michael Alfieri via mailing address: C/o Genocea Biosciences, Inc., 100 Acorn Park Drive, 5th Floor, Cambridge Ma 02140.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
